Clinical Trials Logo

Citation(s)

A Prospective, Phase II Study of MR-Linac Guided Adaptive Fractionated Stereotactic Radiotherapy for Brain Metastases From Non-small Cell Lung Cancer

Details for clinical trial NCT04946019